Showing results (1111-1120 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|May 7, 2014
Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioningDominik Wolf, Annkristin Heine, Peter BrossartOncoimmunology|May 7, 2014
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapyYuting Ma, Sandy Adjemian, Lorenzo Galluzzi, et al.Oncoimmunology|May 7, 2014
Is tumor (R)ejection by the immune system the "5th R" of radiobiology?Encouse B Golden, Silvia C FormentiOncoimmunology|May 7, 2014
Trial Watch: DNA vaccines for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.Oncoimmunology|January 27, 2017
Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patientsYumi Nonomura, Atsushi Otsuka, Chisa Nakashima, et al.Oncoimmunology|January 27, 2017
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesisSilvio Bandini, Marco Macagno, Albana Hysi, et al.Oncoimmunology|February 16, 2017
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiotaJonathan M Pitt, Marie Vétizou, Ivo Gomperts Boneca, et al.Oncoimmunology|February 16, 2017
Prophylactic vaccination targeting ERBB3 decreases polyp burden in a mouse model of human colorectal cancerDavid J Bautz, Ang T Sherpa, David W ThreadgillOncoimmunology|February 16, 2017
FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survivalFelix Eisenhut, Lisanne Heim, Sonja Trump, et al.Oncoimmunology|February 16, 2017
Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screeningMatthias Schröder, Simone Loos, Svenja Kerstin Naumann, et al.Pageof 379